Recently, Huadong Pharmaceutical announced that its wholly-owned Sun Company Huadong Medical will acquire all the shares of Sinclair Pharma plc in the UK by cash offer. Sinclair Pharma plc is a specialized company specializing in the field of medical beauty products, mainly engaged in the research and development, production and sales of medical beauty products. The main products include absorbable microspheres, beauty lines and hyaluronic acid.
From medicine to medical beauty, this acquisition is not the first time for Huadong Medicine. In 2013, Huadong Ningbo Pharmaceutical Co., Ltd., a subsidiary of Huadong Pharmaceutical Holdings Co., Ltd., obtained the exclusive agency rights for the Korean LG product Yilan Hyaluronic Acid in China.
Coincidentally, in recent years, cross-border investment in the acquisition of medical and beauty enterprises is not only a Huadong pharmaceutical company, but also companies such as Evergrande, Suning Global, Langzi, Huabang Pharmaceutical, and Sinopharm Group. What kind of attraction does medical beauty have in the end, which will allow major companies to settle in? Can these companies eat this piece of cake "elegantly"?
Where is the appeal of medical beauty?
The major companies have laid a cross-border layout of medical beauty, and people can't help but re-examine the industry. After all, the path of medical beauty at first was not so "disputed". The illegal production and marketing of medical devices, unlicensed medical treatment, illegal use of WeChat and Weibo, and so on have always existed in the entire industry. The label of "profiteering" has also been attached to the "head" of the medical and aesthetic industry. There are numerous examples of the "profiteering" in the medical and beauty industry. For example, the average price of a hyaluronic acid raw material may be about 173 yuan, compared with the ex-factory price, the price of hyaluronic acid in the medical terminal has been up to 9 times. However, the high cost of obtaining passengers will erode more than 50% of gross profit, resulting in lower net profit of medical institutions.
For the user, medical beauty is not just needed, and if it involves plastic surgery, it is likely to need a "moving knife". In fact, in the post-70s and post-80s concepts, the acceptance is not very high. However, this situation, in the eyes of the new oxygen CEO Jin Xing, with the arrival of the 90s, after the 00, has been disappearing, the entire Chinese medical and beauty market is constantly changing.
Thanks to the admission after the 90s, the Chinese medical and beauty market has shown a state of rapid growth in the past few years. According to the data of the 2017 China Medical Aesthetics White Paper, the growth rate of China's medical beauty in the year of 2017 exceeded 40%, and the total number exceeded 10 million. More than Brazil officially became the second largest medical beauty market in the world after the United States. According to the data of "New Oxygen 2018 Medical Aesthetics White Paper", the size of China's medical and beauty market may reach 224.5 billion yuan this year, a year-on-year growth rate of over 27%, and there is still 6 times growth in the future, which means the domestic medical and beauty market. There will be a potential of trillions of scale.
At the same time, users' perceptions of medical beauty are also changing. In the eyes of many 70s and 80s, plastic surgery may not be worth mentioning, but in the eyes of after 90s and after 00, many 90s are chasing after Han Xing, influenced by the Korean Wave. Larger, therefore, their attitude towards medical beauty is also more open.
In addition, in recent years, the emergence of the vertical platform of medical beauty has also enabled the medical and aesthetic industry to develop in a more standardized direction. The emergence of new oxygen, pleasing beauty and more beautiful is a good example. With the application of big data, artificial intelligence and other technologies in medical beauty, medical beauty can more accurately meet user needs.
Can cross-border companies eat this "cake" "elegantly"?
The market for medical beauty has been expanding, which has caused many listed companies like Huadong Medicine to have a coveted heart. For example, Suning Global, which was reported by Yiou Dahe Health. In January 2016, Suning Global's subsidiary “Suning Global Health†and South Korea ID Group jointly established a joint venture in the mainland to open a number of plastic surgery chain hospitals for medical beauty business. In July of the same year, Suning Global Health participated in the Medical and Aesthetic Industry Fund for 450 million yuan, mainly engaged in the equity investment business mainly in the medical and beauty industry.
In addition, Langzi shares, which are deeply cultivated in the production and sales of women's wear, are also eager to try. In June 2016, Langzi shares spent 300 million to acquire six plastic surgery hospitals such as Milan Bai Yu and Jing Skin Plastic Surgery Hospital. In October of the same year, Langzi shares established a wholly-owned subsidiary, Langzi Medical Management Co., Ltd., focusing on the medical plastic surgery industry. In 2018, Langzi shares once again acquired Gao Yisheng Medical Plastic Surgery Hospital, in order to enter the medical beauty and then the next city.
Medical beauty is a "big cake", but how to eat it "elegantly" is also a very important issue.
In the first decade of the Chinese medical and beauty industry, the number of institutions that can provide medical beauty products was few and far, and qualified plastic surgeons and professional medical institutions were too scarce. Therefore, as long as there is a certain strength of the medical and beauty enterprises can be "out of the box". But now, the "cake" of medical beauty is getting bigger and bigger, but at the same time, more and more people want to divide this "cake", and the price war is getting more and more fierce. The medical beauty market is constantly experiencing cruelty. Shuffle. For cross-border enterprises, their own “home†in the field of medical beauty is not enough. If you want to survive in the medical and beauty industry and gain competitive advantage, how to build a good brand and provide quality medical services will be faced by enterprises. important question.
In addition, after the company's cross-border acquisition of medical and beauty companies, the subsequent integration in research and development, production, sales, investment and financing, finance, human resources, suppliers, public relations, government regulation and other aspects will also be a big problem. The announcement of Huadong Medicine shows that once there is a disagreement with the integration of the acquisition company Sinclair Pharma plc, this will affect the operating performance of Huadong Pharmaceutical's entire listed company.
Vehicle Camera,Fleet Camera Surveillance Solution,Car Camera,Onboard Camera,Car Security Camera
SHENZHEN SANAN TECHNOLOGY CO.,LTD , https://www.sanan-cctv.com